Clinical Trial Update: A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating Deferoxamine (DFO) for treating leptomeningeal metastases is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastases

Drugs mentioned

• Deferoxamine (deferoxamine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leptomeningeal Metastases | Phase 1 | Status: RECRUITING